Iambic Therapeutics(IAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IAM Iambic Therapeutics

Closed 11-05 16:00:00 EST

11.64

-1.76

-13.13%

盘后10.65

-0.99-8.49%

19:30 EST

High13.22	Low10.55	Vol751.87K
Open13.16	D1 Closing13.40	Amplitude19.93%
Mkt Cap551.75M	Tradable Cap109.13M	Total Shares47.40M
T/O8.74M	T/O Rate8.02%	Tradable Shares9.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IAM","market":"US","secType":"STK","nameCN":"Iambic Therapeutics","latestPrice":11.64,"timestamp":1793912400000,"preClose":13.4,"halted":0,"volume":751872,"hourTrading":{"tag":"盘后","latestPrice":10.652,"preClose":11.64,"latestTime":"19:30 EST","volume":1246,"amount":14494.464,"timestamp":1793925004213,"change":-0.988,"changeRate":-0.08488,"amplitude":0.134631},"delay":0,"changeRate":-0.13134328358208952,"floatShares":9375000,"shares":47400796,"eps":-1.988,"marketStatus":"Closed","change":-1.76,"latestTime":"11-05 16:00:00 EST","open":13.16,"high":13.22,"low":10.55,"amount":8740372.151808001,"amplitude":0.199254,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.988,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793955600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1792036800000,"exchange":"NASDAQ","adjPreClose":13.4,"preHourTrading":{"tag":"盘前","latestPrice":13.14,"preClose":13.4,"latestTime":"09:29 EST","volume":323,"amount":4337.7698439999995,"timestamp":1793888999092,"change":-0.26,"changeRate":-0.019403,"amplitude":0.026866},"postHourTrading":{"tag":"盘后","latestPrice":10.652,"preClose":11.64,"latestTime":"19:30 EST","volume":1246,"amount":14494.464,"timestamp":1793925004213,"change":-0.988,"changeRate":-0.08488,"amplitude":0.134631},"volumeRatio":2.258214},"requestUrl":"/m/hq/s/IAM/wiki","defaultTab":"wiki","newsList":[{"id":"2678456280","title":"BIO-key Deploys Identity Security Solution to New Customer Within a Middle East Government’s National Security Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2678456280","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678456280?lang=en_us&edition=fundamental","pubTime":"2026-10-28 16:00","pubTimestamp":1793174400,"startTime":"0","endTime":"0","summary":"RIYADH, Saudi Arabia and HOLMDEL, N.J., Oct.  28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global provider of Identity and Access Management (IAM) and biometric authentic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/28/3389904/0/en/bio-key-deploys-identity-security-solution-to-new-customer-within-a-middle-east-government-s-national-security-ecosystem.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDS","BKYI","SPUU","SPXS","SPYU","CRWC","SMAX","SPDN","NSEC","PSWD","SPYH","BK4585","BK4110","SPYQ","BK4139","IVV","YSPY","SPXL","VOO","SPY","UPRO","DMAX","SPAM","CRWL","CRDT","SPYM","MFA","BK4107","IAM","BK4097","HAKY","SSO","BK4588","HIBL","SH","SPXU","MMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678989771","title":"Iambic Reports Durable Responses to Iam1363 in Phase 1/1b Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678989771","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678989771?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:03","pubTimestamp":1793016224,"startTime":"0","endTime":"0","summary":"Iambic Reports Durable Responses to IAM1363 in Phase 1/1b Cancer TrialIambic Therapeutics presented updated Phase 1/1b results for HER2 inhibitor IAM1363 at ESMO in Madrid on October 23, 2026.Treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDLJRWsH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678669198","title":"Iambic Presents Updated Iam1363 Clinical Data at Esmo 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with Her2-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2678669198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678669198?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:01","pubTimestamp":1793016099,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nFWN46C175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IAM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678419865","title":"Iambic Therapeutics - More than Half of Participants at 960 Mg Remain on Study Beyond One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2678419865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678419865?lang=en_us&edition=fundamental","pubTime":"2026-10-26 20:01","pubTimestamp":1793016099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nFWN46C175:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IAM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894779","title":"Biotech Is Beating AI in the October IPO Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894779","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894779?lang=en_us&edition=fundamental","pubTime":"2026-10-25 19:25","pubTimestamp":1792927524,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4235.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/4235.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Biotech Is Beating AI in the October IPO Market","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYCA","RTSN","ANTW","CTY","TRXB","IAM"],"isVideo":true,"video":{"duration":135,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/4235.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4235.webp","audio_url":"https://static.tigerbbs.com/58c8da70a87eb4252f1d651f5ba8710b.mp3","isAI":true},"gpt_icon":0},{"id":"2676632380","title":"Iambic Therapeutics Director Evan Lockwood Rachlin Reports $11.5 Million Common Share Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2676632380","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676632380?lang=en_us&edition=fundamental","pubTime":"2026-10-20 07:48","pubTimestamp":1792453699,"startTime":"0","endTime":"0","summary":"Iambic Therapeutics Director Evan Lockwood Rachlin Reports $11.5 Million Common Share AcquisitionIambic Therapeutics director Evan Lockwood Rachlin reported an indirect purchase of 718,750 common shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDL5mKVrk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Iambic Therapeutics Director Evan Lockwood Rachlin Reports $11.5 Million Common Share Acquisition","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676859636","title":"Small U.S. Stocks End Mixed as Disc Medicine Leads, Iambic Therapeutics Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2676859636","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676859636?lang=en_us&edition=fundamental","pubTime":"2026-10-20 04:20","pubTimestamp":1792441200,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index gained 0.3%, while the S&P Small Cap 600 Index was down 0.1%.Among companies with a market value of $1 billion to $6.7 billion, Disc Medicine Inc. was the best performer during the session, surging 39%, followed by Veradermics Inc., which jumped 12%. Agios Pharmaceuticals Inc. shares surged 12%, Parabilis Medicines Inc. surged 11%, and shares of Arcutis Biotherapeutics Inc. surged 11%.Iambic Therapeutics Inc. was the biggest laggard, dropping 32%, followed by shares of Almonty Industries Inc., which dropped 10%. Shares of Seneca Foods Corp. Cl B dropped 8.7%, Ocular Therapeutix Inc. shares plunged 8.4%, and Trump Media & Technology Group Corp. plunged 8.0%.Major U.S. stock indexes ended Monday mixed with the Nasdaq Composite Index rising 1.1%. Meanwhile, the S&P 500 Index increased 0.4%, and the Dow Jones Industrial Average declined 0.1%.Data so","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676684210","title":"Nvidia-Backed Iambic Therapeutics Tumbles Below IPO Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2676684210","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676684210?lang=en_us&edition=fundamental","pubTime":"2026-10-19 22:45","pubTimestamp":1792421150,"startTime":"0","endTime":"0","summary":"BUZZ-Nvidia-backed Iambic Therapeutics tumbles below IPO price** Shares of Iambic TherapeuticsIAM.O, drug developer backed by AI giant NvidiaNVDA.O, tumble as much as 41% to $14.10 in their third sess","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nL6N4650Z3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676113512","title":"Iambic Therapeutics Completes IPO and Updates Governance","url":"https://stock-news.laohu8.com/highlight/detail?id=2676113512","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676113512?lang=en_us&edition=fundamental","pubTime":"2026-10-17 05:28","pubTimestamp":1792186113,"startTime":"0","endTime":"0","summary":"Iambic Therapeutics, Inc. ( ($IAM) ) has provided an update. On October 16, 2026, Iambic Therapeutics, Inc. completed its initial public offering a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iambic-therapeutics-completes-ipo-and-updates-governance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iambic-therapeutics-completes-ipo-and-updates-governance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAM","SPCK","KCE","BK4127","FRHC","REDS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676519968","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2676519968","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676519968?lang=en_us&edition=fundamental","pubTime":"2026-10-17 02:54","pubTimestamp":1792176876,"startTime":"0","endTime":"0","summary":"Iambic Therapeutics  shares surged over 16% after midday Friday, a day after the company made its debut on Nasdaq with an initial public offering of $16 per share.Intraday trading volume was more than 2.2 million shares, compared with about 2.0 million in the previous day.City Therapeutics  said late Thursday it priced its upsized initial offering of about 11.1 million shares at $18 each, raising about $200 million for the clinical-stage company.Shares climbed up over 16% in their debut on Nasdaq, with intraday trading volume of more than 930,000 shares.Exascale Labs  said Thursday it struck a deal to sell 12 Nvidia  HGX B300 GPU servers, together with network equipment and management servers, deployment services and 36 months of IT operation services, to Sunon.The total contract value for the provision of equipment and services is about $8.2 million, the firm said.Shares soared 75%, with intraday trading volume rising to over 155.1 million from a daily average of about 540,000.Price: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTY","BK4116","IAM","XLAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125737678","title":"From Algorithms To Oncology: Why IAM Jumped On Day One","url":"https://stock-news.laohu8.com/highlight/detail?id=1125737678","media":"Bellwether Stocks Movement","labels":["videos"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125737678?lang=en_us&edition=fundamental","pubTime":"2026-10-16 21:50","pubTimestamp":1792158613,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3767.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3767.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Algorithms To Oncology: Why IAM Jumped On Day One","news_tag":"videos","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","NVOH","AMGN","ABBV","LLII","MRNY","MRK","VIR","BMY","BIIB","JNJ","MRNX","LLYX","AZN","GSK","ABT","NVAX","PFE","NVOX","VERU","NVO","NVOC","SNY","IAM","ELIL","MRNA","GSKH","BNTX","REGN","NVS","ELIS","GILD"],"isVideo":true,"video":{"duration":97,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3767.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3767.webp","audio_url":"https://static.tigerbbs.com/423b01de7fc94402d0de38156c508de0.mp3","isAI":true},"gpt_icon":0},{"id":"1166353878","title":"Cathie Wood's ARK Reveals Latest Portfolio Moves: Adds More CoreWeave, Buys Nearly $19 Million in Iambic Shares, Trims Amazon and Palantir","url":"https://stock-news.laohu8.com/highlight/detail?id=1166353878","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166353878?lang=en_us&edition=fundamental","pubTime":"2026-10-16 15:11","pubTimestamp":1792134679,"startTime":"0","endTime":"0","summary":"ARK Investment Management, led by Cathie Wood, disclosed its trading records for October 15, continuing to add to artificial intelligence infrastructure and biotechnology companies while trimming...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","IE00B775SV38.USD","LU0048584097.USD","IE00BK4W5M84.HKD","BK4539","LU1974910355.USD","LU2954938101.SGD","LU1037948897.HKD","LU0082616367.USD","HULL","CRWU","BK4534","LU2430703251.USD","SG9999014906.USD","LU1935043023.USD","LU1267930573.SGD","LU1941712264.USD","SG9999002232.USD","LU2362540622.SGD","LU2023250843.SGD","IE0034235303.USD","LU2471134796.USD","LU0528227936.USD","IE00B1BXHZ80.USD","IE00BMPRXN33.USD","LU2247934214.USD","AMAA","SGXZ99366536.SGD","IE000W1ABFV2.USD","LU1883839398.USD","LU1145028129.USD","BK4550","LU0276348264.USD","BK4116","LU2065170008.USD","BK4548","IE00B5TLWC47.USD","LU1116320901.HKD","LU0127658192.USD","LU2106854487.HKD","AZYY","HK0000304797.USD","LU1084165304.USD","LU1235294995.USD","LU1868836914.USD","BK4585","IE0004086264.USD","LU0080751232.USD","LU2271345857.HKD","BK4507","LU0345770308.USD","SG9999014880.SGD","LU1066051811.HKD","LU0823434740.USD","IGV","LU2108987350.USD","LU1116320737.USD","LU0345769631.USD","IE00B19Z9Z06.USD","LU2077746001.SGD","PTIR","LU0965509101.SGD","IE0003U64NQ7.SGD","LU2237957902.USD","SPLTRmain","LU0820562030.AUD","LU0672654240.SGD","SGXZ51526630.SGD","IE0001KFT4U8.USD","BK4547","LU0061474960.USD","LU2275660780.HKD","LU1778281490.HKD","IE00B4JS1V06.HKD","IE00BFSS7M15.SGD","LU0320765489.SGD","BK4535","LU1861127337.USD","PLTA","LU0072461881.USD","LU2543165471.USD","LU1674673428.USD","LU2471134523.USD","USAW.SI","LU0061475181.USD","LU2471134952.CNY","IE0004091025.USD","LU0128525929.USD","LU0354030511.USD","LU0211327993.USD","LU1201861249.SGD","LU0210528500.USD","IE000MB6IJN5.SGD","LU1316542783.SGD","IE00BKPKM429.USD","LU2746668974.SGD","LU2505996509.AUD","IE00B19Z9P08.USD","LU0109391861.USD","LU1366192091.USD","LU0029864427.USD","LU0210536198.USD","LU0965509283.SGD","IE00B19Z3581.USD","LU2168564065.EUR","LU0494093205.USD","LU2242649171.HKD","LU0784385840.USD","IE00BYQQ9H92.USD","IE00BFSS8Q28.SGD","LU0289960550.SGD","LU1066051498.USD","LU0316494557.USD","PLTL","LU0158827948.USD","LU0310800379.SGD","LU0210533765.USD","LU2265009873.SGD","LU0456855351.SGD","LU2602419157.SGD","LU1069344957.HKD","LU0174119429.USD","SGXZ81514606.USD","BK4592","IAM","IE0002270589.USD","LU1323610961.USD","LU0056508442.USD","LU1629891620.HKD","CRWX","LU0077335932.USD","LU0310799852.SGD","LU0345768153.USD","PLOO","AMZZ","LU0175139822.USD","LU2092937148.SGD","LU2860962120.EUR","LU1861559042.SGD","BK4612","IE00B7SZLL34.SGD","LU0719512351.SGD","LU2211817866.USD","IE00BKVL7J92.USD","LU2430703095.HKD","LU2097829019.USD","LU1064131342.USD","LU1804176565.USD","LU0203201768.USD","BK4579","SG9999001077.SGD","SG9999014914.USD","LU2637965513.SGD","LU1941712348.USD","LU0882574139.USD","IE00BZ9MQY76.HKD","LU0345774391.USD","LU0312595415.SGD","LU1201861165.SGD","LU2087621335.USD","LU2360032135.SGD","PLTR","LU1839511570.USD","LU1880398554.USD","LU2756315664.SGD","LU0107464264.USD","LU0345770993.USD","LU1301847155.USD","LU0158827781.USD","BK4524","LU1934455194.USD","LU2487616109.SGD","LU1815333072.USD","LU1037948541.HKD","LU2063271972.USD","LU2463028550.USD","LU0251132253.USD","LU1066051225.USD","LU2089284900.SGD","LU2417539215.USD","LU0784384876.USD","LU2403377893.USD","LU1935042991.SGD","LU0787776722.HKD","LU2746668461.USD","LU1435385759.SGD","SG9999018865.SGD","IE00BQXX3C00.GBP","LU2242650005.HKD","LU0640476718.USD","BK4023","LU0097036916.USD","IE00BFXG0V08.USD","LU1791710400.SGD","LU0072462426.USD","IE00B19Z8X17.USD","LU0079474960.USD","LU1988902786.USD","IE00B4YYXB79.USD","IE00BKDWB100.SGD","LU2456880835.USD","LU2764263039.SGD","LU2362541273.HKD","LU0466842654.USD","IE00BJTD4V19.USD","IE00B19Z8W00.USD","LU0096362180.USD","IE00B1XK9C88.USD","IE00BWXC8680.SGD","HK0000532082.HKD","LU0985320562.USD","LU1280957306.USD","LU1803068979.SGD","SG9999002224.SGD","LU0823421333.USD","LU0980610538.SGD","LU0949170426.SGD","AIPI","LU0096364046.USD","LU2462591350.SGD","SG9999018857.SGD","IE00BJJMRY28.SGD","LU2430703178.SGD","LU1551013342.USD","LU1674673691.USD","LU0302445910.USD","LU2168564222.USD","LU0648001328.SGD","GUNZ","IE00B5949003.HKD","LU0109392836.USD","BK4551","LU1935043536.SGD","SGXZ80539844.SGD","BK4122","LU2125154778.USD","IE00B19Z9505.USD","PLTI","LU1852331112.SGD","LU0353189763.USD","LU1119994496.HKD","LU0211328371.USD","LU1880398471.USD","LU0162691827.USD","LU1718418525.SGD","LU0238689110.USD","LU1496350171.SGD","LU0154236417.USD","LU2028103732.USD","BK4604","LU1035775433.USD","LU2213496289.HKD","IE000YTNTUN2.SGD","LU0149725797.USD","LU0354030438.USD","LU0130102774.USD","CRWG","BK4139","BK4543","LU1791710582.SGD","LU0820561818.USD","BK4554","LU2236285917.USD","LU0889565833.HKD","BK4220","LU2111349929.HKD","IE000F7OJYX1.SGD","LU2750360997.AUD","AMZD","LU0708995401.HKD","BK4598","LU2452424414.USD","IE00BMPRXQ63.HKD","LU1244550221.USD","AMZY","PLTU","BK4503","LU0256863811.USD","BK4527","OGIG","IE000SO60NU8.SGD","LU2168563687.JPY","HK0000304805.HKD","IE00B7KXQ091.USD","SGXZ23171101.USD","LU0784383803.USD","IE000ITXATA3.USD","LU2023250504.SGD","SAMZNmain","LU0198837287.USD","HK0000914660.USD","LU1691799644.USD","LU1244550494.USD","LU2089283258.USD","LU1861558580.USD","AMZW","LU0342679015.USD","LU0157215616.USD","IE00BJLML261.HKD","LU0215105999.USD","BK4561","IE00BQXX3D17.EUR","LU0048573561.USD","LU0823434583.USD","LU1232071149.USD","LU0251131958.USD","RXRX","LU2023250330.USD","LU2125154935.USD","LU1868837136.USD","IE00B775H168.HKD","LU1267930730.SGD","LU2999663052.SGD","LU2462591277.SGD","IE00B19Z3B42.SGD","LU0823411888.USD","LU2592432038.USD","LU0070302665.USD","SG9999017495.SGD","LU1868837300.USD","IE00BZ1G4Q59.USD","LU1720051017.SGD","LU2326559502.SGD","LU1989764664.SGD","HK0000914686.HKD","LU1267930490.SGD","IE0009G5SDU7.USD","LU1868836757.USD","PLTD","LU0170899867.USD","LU1429558221.USD","LU0957791311.USD","LU2552382132.HKD","SG9999014898.SGD","BK4613","LU2896262040.SGD","IE00BQXX3F31.USD","BK4533","LU0871640123.AUD","LU2083900584.USD","PLTZ","WANT","BK4532","CWVX","IE000M9KFDE8.USD","IE00BMPRXR70.SGD","LU0133085943.USD","LU2357305700.SGD","LU0965509010.AUD","LU0320765059.SGD","LU0345769128.USD","IE00BJTD4N35.SGD","LU1548497426.USD","LU0345774631.USD","LU0861579265.USD","LU1720051108.HKD","LU1934455863.HKD","LU0308772762.SGD","LU0390134368.USD","LU0784385170.HKD","LU1917777945.USD","IE00BN29S564.USD","IE00BJJMRX11.SGD","IE0009356076.USD","LU2065171402.SGD","LU1823568750.SGD","SG9999004303.SGD","LU2471134879.HKD","LU2237957811.SGD","LU1244550577.SGD","ONLN","AMZG","BK4566","BK4609","PLYY","LU2552382058.USD","SG9999015978.USD","LU0788109477.HKD","IE000WAW04H5.SGD","LU0130103400.USD","LU2552382215.SGD","LU2461242641.AUD","LU2168564495.EUR","LU0786609619.USD","LU2420271590.USD","LU0965508806.USD","LU2168564149.EUR","LU2362541513.USD","RTH","LU0208291251.USD","LU0683600562.USD","LU1066053197.SGD","LU1496350502.SGD","LU0267386448.USD","LU0345768740.USD","LU1914381329.SGD","SHLD","LU0708994859.HKD","LU0943347566.SGD","AMZU","LU0823421416.USD","LU0648000940.SGD","EYES","IE0000B7K699.USD","LU2211815571.USD","LU2361045086.USD","LU0256863902.USD","SG9999000418.SGD","LU0203202063.USD","ILDR","LU2764263203.CNY","LU1868836591.USD","LU0289941410.SGD","LU1935042215.USD","LU0070217475.USD","LU0143551892.USD","LU2381873111.SGD","LU2065169927.USD","BK4596","CWII","LU0061474705.USD","LU1127390331.HKD","IE000KEQY171.SGD","SGXZ44715902.SGD","AMZO","LU2756315318.SGD","PLTY","LU2505996681.GBP","LU0011850046.USD","LU0234570918.USD","PLTW","LU1261432733.SGD","LU1934455277.USD","SG9999015945.SGD","LU0265550946.USD","LU1153585028.USD","LU1046421795.USD","LU2087625088.SGD","CLIX","LU0323591593.USD","CRWV","LU0053666078.USD","CORD","BK4611","PLTG","BK4538","IE000BZT7R73.USD","LU0251142724.SGD","LU1074936037.SGD","IE0004445239.USD","LU1551013425.SGD","SGXZ31699556.SGD","SG9999015952.SGD","LU0964807845.USD","IE00B3S45H60.SGD","LU1366333091.USD","LU2720916845.USD","LU1814569148.SGD","LU2065171311.SGD","IE00BK4W5L77.USD","IE00B3SWFQ91.USD","LU2250418816.HKD","LU0265550359.USD","LU2361044865.SGD","BK4581","LU1633808545.USD","LU2764262908.HKD","IE0005OL40V9.USD","LU0348723411.USD","LU0642271901.SGD","LU2092627202.USD","IE00B894F039.SGD","LU0820561909.HKD","AMZN","PLT","LU0689472784.USD","LU2317271919.USD","LU2361044949.HKD","LU2023251221.USD","LU2237438978.USD","BK4588","LU2054465674.USD","LU1979441026.SGD","LU2360106780.USD","LU0234572021.USD","LU0353189680.USD","LU1935042488.USD","LU2462157665.USD","LU2264538146.SGD","LU2750360641.GBP","LU1989764748.USD","IE0004445015.USD","LU0724617625.USD","LU0314104364.USD","AMZP","LU0742534661.SGD","LU1935043452.HKD","LU0417517546.SGD","SG9999015986.USD","LU0138981039.USD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554476","title":"Cathie Wood’s ARK Investment buys 1.18M shares of Iambic Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554476","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675554476?lang=en_us&edition=fundamental","pubTime":"2026-10-16 09:25","pubTimestamp":1792113919,"startTime":"0","endTime":"0","summary":"21:21 EDT Cathie Wood’s ARK Investment buys 1.18M shares of Iambic Therapeutics (IAM) today Published first on TheFly – the ultimate source for rea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-18m-shares-of-iambic-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-18m-shares-of-iambic-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKQ","ARKF","ARKW","ARKX","IAM","SARK","ARKK","BK4588","ARKG","BK4544"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675534714","title":"Nvidia-Backed Iambic Therapeutics Jumps in Debut After $150 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2675534714","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675534714?lang=en_us&edition=fundamental","pubTime":"2026-10-16 02:31","pubTimestamp":1792089091,"startTime":"0","endTime":"0","summary":"BUZZ-Nvidia-backed Iambic Therapeutics jumps in debut after $150 million IPO** Iambic TherapeuticsIAM.Oshares jump 19% to $19.08 in Nasdaq debut after $150 million US IPO** Nvidia-backed drug develope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nL6N4610OC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675534697","title":"AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2675534697","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675534697?lang=en_us&edition=fundamental","pubTime":"2026-10-16 01:57","pubTimestamp":1792087039,"startTime":"0","endTime":"0","summary":"Shares in Nvidia ($NVDA)-backed cancer-fighting biotech Iambic Therapeutics ($IAM) soared 13% on its first day of trading following its U.S. IPO. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ai-cancer-fighting-iambic-therapeutics-stock-iam-rockets-13-after-150m-ipo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ai-cancer-fighting-iambic-therapeutics-stock-iam-rockets-13-after-150m-ipo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675313995","title":"Iambic Therapeutics Shares Rise in Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2675313995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675313995?lang=en_us&edition=fundamental","pubTime":"2026-10-16 01:02","pubTimestamp":1792083771,"startTime":"0","endTime":"0","summary":"Iambic Therapeutics  shares rose more than 10% in their Nasdaq debut Thursday, trading above the company's $16 IPO price.Iambic priced its IPO at $16 per share, selling 9.375 million shares and raising $150 million in gross proceeds before underwriting discounts, commissions and other expenses.Price: 17.65, Change: +1.65, Percent Change: +10.31","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REDS","IAM","LCLG","BK7091","FRHC","IPO","IPOS","BK4127","NQmain","IAM.AU","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675953952","title":"NASDAQ Trade Halt Volatility Trading Pause at 12:12 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2675953952","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675953952?lang=en_us&edition=fundamental","pubTime":"2026-10-16 00:12","pubTimestamp":1792080772,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 12:12 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nAQN2MOADP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675435304","title":"Iambic Therapeutics Prices $150 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2675435304","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675435304?lang=en_us&edition=fundamental","pubTime":"2026-10-15 16:17","pubTimestamp":1792052250,"startTime":"0","endTime":"0","summary":"Iambic Therapeutics  priced its initial public offering of about 9.38 million shares at $16.00 each, it said late Wednesday, targeting about $150 million in gross proceeds.The company, which is offering all the shares in the sale, said it has granted underwriters a 30-day option to purchase up to about 1.41 million additional shares.Shares are expected to begin trading on the Nasdaq Global Select Market on Thursday, under the ticker symbol \"IAM,\" Iambic said.The offering is expected to close Friday, subject to customary closing conditions, according to the company.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IAM","BK7091","IPOS","IAM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675835304","title":"NASDAQ Trade Halt Reason not Available at 04:00 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2675835304","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675835304?lang=en_us&edition=fundamental","pubTime":"2026-10-15 16:00","pubTimestamp":1792051202,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTREASON NOT AVAILABLE AT 04:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nAQN2MO4Z3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118283921","title":"Nvidia-backed AI cancer drug developer Iambic (IAM.US) debuts on Nasdaq: priced at midpoint of range, raising $150 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1118283921","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118283921?lang=en_us&edition=fundamental","pubTime":"2026-10-15 10:04","pubTimestamp":1792029884,"startTime":"0","endTime":"0","summary":"Clinical-stage cancer drug developer and technology company Iambic Therapeutics Inc. raised $150 million in its U.S. IPO, pricing shares at the midpoint of its marketed range.According to a Wednesday...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iambic.ai","stockEarnings":[{"period":"1week","weight":-0.0934},{"period":"1month","weight":-0.1625},{"period":"ytd","weight":-0.1625}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Iambic Therapeutics, Inc. is a technology and clinical-stage life sciences company using its Molecular Transformer and proprietary molecular intelligence platform to transform biopharmaceutical discovery. The platform combines large-scale artificial intelligence with automated, scalable chemistry and biology experiments to discover and develop novel medicines.","exchange":"NASDAQ","name":"Iambic Therapeutics","nameEN":"Iambic Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iambic Therapeutics(IAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Iambic Therapeutics(IAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Iambic Therapeutics,IAM,Iambic Therapeutics股票,Iambic Therapeutics股票老虎,Iambic Therapeutics股票老虎国际,Iambic Therapeutics行情,Iambic Therapeutics股票行情,Iambic Therapeutics股价,Iambic Therapeutics股市,Iambic Therapeutics股票价格,Iambic Therapeutics股票交易,Iambic Therapeutics股票购买,Iambic Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iambic Therapeutics(IAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Iambic Therapeutics(IAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction